{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:24:49Z","timestamp":1793391889000,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,26]],"date-time":"2020-12-26T00:00:00Z","timestamp":1608940800000},"content-version":"vor","delay-in-days":55,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jlr.org"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1194\/jlr.ra120000909","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T20:45:11Z","timestamp":1598906711000},"page":"1410-1423","update-policy":"https:\/\/doi.org\/10.1194\/jlr.f110.005975","source":"Crossref","is-referenced-by-count":22,"title":["Assessing the role of glycosphingolipids in the phenotype severity of Fabry disease mouse model"],"prefix":"10.1016","volume":"61","author":[{"given":"Siamak","family":"Jabbarzadeh-Tabrizi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Boutin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taniqua S.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouna","family":"Taroua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Schiffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Auray-Blais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Song","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.RA120000909_bib1","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","article-title":"Enzymatic defect in Fabry disease: ceramide trihexosidase deficiency","volume":"276","author":"Brady","year":"1967","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.RA120000909_bib2","unstructured":"Desnick, R. J., Y. A., Ioannou, and C. M., Eng, . 2001. \u03b1-Galactosidase A deficiency: Fabry disease. In The Metabolic and Molecular Bases of Inherited Disease. C. R. Scriver, A. L. Beaudet, W. S. Sly, et al., editors. McGraw-Hill, New York. 3733\u20133774."},{"key":"10.1194\/jlr.RA120000909_bib3","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","author":"Aerts","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.RA120000909_bib4","doi-asserted-by":"crossref","first-page":"13382","DOI":"10.1021\/acs.analchem.7b03609","article-title":"Separation and analysis of lactosylceramide, galabiosylceramide, and globotriaosylceramide by LC-MS\/MS in urine of Fabry disease patients","volume":"89","author":"Boutin","year":"2017","journal-title":"Anal. Chem."},{"key":"10.1194\/jlr.RA120000909_bib5","doi-asserted-by":"crossref","first-page":"5971","DOI":"10.1073\/pnas.0607285104","article-title":"Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals","volume":"104","author":"Speak","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.RA120000909_bib6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2119\/molmed.2015.00088","article-title":"Efficacy of enzyme and substrate reduction therapy with a novel antagonist of glucosylceramide synthase for Fabry disease","volume":"21","author":"Ashe","year":"2015","journal-title":"Mol. Med."},{"key":"10.1194\/jlr.RA120000909_bib7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.omtm.2017.05.003","article-title":"Lentivector iterations and pre-clinical scale-up\/toxicity testing: targeting mobilized CD34(+) cells for correction of Fabry disease","volume":"5","author":"Huang","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1194\/jlr.RA120000909_bib8","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1172\/JCI9711","article-title":"Reduction of globotriaosylceramide in Fabry disease mice by substrate deprivation","volume":"105","author":"Abe","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.RA120000909_bib9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10545-006-0484-8","article-title":"The Dutch Fabry cohort: diversity of clinical manifestations and Gb3 levels","volume":"30","author":"Vedder","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1194\/jlr.RA120000909_bib10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/gim.2018.31","article-title":"Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis","volume":"21","author":"Maruyama","year":"2019","journal-title":"Genet. Med."},{"key":"10.1194\/jlr.RA120000909_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13023-014-0111-y","article-title":"Globotriaosylsphingosine (lyso-Gb3) might not be a reliable marker for monitoring the long-term therapeutic outcomes of enzyme replacement therapy for late-onset Fabry patients with the Chinese hotspot mutation (IVS4+919G>A)","volume":"9","author":"Liu","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1194\/jlr.RA120000909_bib12","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1093\/hmg\/ddv070","article-title":"Blocking hyperactive androgen receptor signaling ameliorates cardiac and renal hypertrophy in Fabry mice","volume":"24","author":"Shen","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1194\/jlr.RA120000909_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nbd.2008.09.001","article-title":"Neurophysiological, behavioral and morphological abnormalities in the Fabry knockout mice","volume":"33","author":"Rodrigues","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1194\/jlr.RA120000909_bib14","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ajpath.2014.11.004","article-title":"\u03b1-Galactosidase A knockout mice: progressive organ pathology resembles the type 2 later-onset phenotype of Fabry disease","volume":"185","author":"Bangari","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1194\/jlr.RA120000909_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1042\/BJ20130825","article-title":"A symptomatic Fabry disease mouse model generated by inducing globotriaosylceramide synthesis","volume":"456","author":"Taguchi","year":"2013","journal-title":"Biochem. J."},{"key":"10.1194\/jlr.RA120000909_bib16","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1242\/jcs.115.4.817","article-title":"Differential expression of receptors for Shiga and cholera toxin is regulated by the cell cycle","volume":"115","author":"Majoul","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1194\/jlr.RA120000909_bib17","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1086\/344053","article-title":"Molecular basis for up-regulation by inflammatory cytokines of Shiga toxin 1 cytotoxicity and globotriaosylceramide expression","volume":"186","author":"Stricklett","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1194\/jlr.RA120000909_bib18","doi-asserted-by":"crossref","first-page":"FSO147","DOI":"10.4155\/fsoa-2016-0027","article-title":"Glycosphingolipid storage in Fabry mice extends beyond globotriaosylceramide and is affected by ABCB1 depletion","volume":"2","author":"Kamani","year":"2016","journal-title":"Future Sci. OA."},{"key":"10.1194\/jlr.RA120000909_bib19","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1073\/pnas.94.6.2540","article-title":"alpha-Galactosidase A deficient mice: a model of Fabry disease","volume":"94","author":"Ohshima","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.RA120000909_bib20","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1194\/jlr.M017178","article-title":"Sex differences of urinary and kidney globotriaosylceramide and lyso-globotriaosylceramide in Fabry mice","volume":"52","author":"Durant","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.RA120000909_bib21","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.4155\/bio-2016-0116","article-title":"Relative distribution of Gb3 isoforms\/analogs in NOD\/SCID\/Fabry mice tissues determined by tandem mass spectrometry","volume":"8","author":"Proven\u00e7al","year":"2016","journal-title":"Bioanalysis."},{"key":"10.1194\/jlr.RA120000909_bib22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cca.2017.01.018","article-title":"Biomarkers associated with clinical manifestations in Fabry disease patients with a late-onset cardiac variant mutation","volume":"466","author":"Auray-Blais","year":"2017","journal-title":"Clin. Chim. Acta."},{"key":"10.1194\/jlr.RA120000909_bib23","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1021\/ac303033v","article-title":"Multiplex analysis of novel urinary lyso-Gb3-related biomarkers for Fabry disease by tandem mass spectrometry","volume":"85","author":"Lavoie","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1194\/jlr.RA120000909_bib24","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1021\/ac404000d","article-title":"Multiplex tandem mass spectrometry analysis of novel plasma lyso-Gb(3)-related analogues in Fabry disease","volume":"86","author":"Boutin","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1194\/jlr.RA120000909_bib25","first-page":"17.23.1","article-title":"Tandem mass spectrometry quantitation of Lyso-Gb3 and six related analogs in plasma for Fabry disease patients","volume":"90","author":"Boutin","year":"2016","journal-title":"Curr Protoc. Hum. Genet."},{"key":"10.1194\/jlr.RA120000909_bib26","doi-asserted-by":"crossref","first-page":"11138","DOI":"10.1016\/S0021-9258(19)78102-2","article-title":"Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues","volume":"269","author":"Kiarash","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.RA120000909_bib27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1042\/BJ20050291","article-title":"Mammalian Lass6 and its related family members regulate synthesis of specific ceramides","volume":"390","author":"Mizutani","year":"2005","journal-title":"Biochem. J."},{"key":"10.1194\/jlr.RA120000909_bib28","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.2174\/092986712800784739","article-title":"Novel gb(3) isoforms detected in urine of fabry disease patients: a metabolomic study","volume":"19","author":"Auray-Blais","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1194\/jlr.RA120000909_bib29","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1212\/WNL.0000000000002478","article-title":"Dorsal horn circuitry: complexity and implications for mechanisms of neuropathic pain","volume":"86","author":"Benarroch","year":"2016","journal-title":"Neurology."},{"key":"10.1194\/jlr.RA120000909_bib30","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1152\/jn.00371.2002","article-title":"Differential response properties of IB(4)-positive and -negative unmyelinated sensory neurons to protons and capsaicin","volume":"89","author":"Dirajlal","year":"2003","journal-title":"J. Neurophysiol."},{"key":"10.1194\/jlr.RA120000909_bib31","doi-asserted-by":"crossref","first-page":"e29280","DOI":"10.7554\/eLife.29280","article-title":"Capillary pericytes mediate coronary no-reflow after myocardial ischaemia","volume":"6","author":"O'Farrell","year":"2017","journal-title":"eLife."},{"key":"10.1194\/jlr.RA120000909_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuron.2004.12.015","article-title":"Topographically distinct epidermal nociceptive circuits revealed by axonal tracers targeted to Mrgprd","volume":"45","author":"Zylka","year":"2005","journal-title":"Neuron."},{"key":"10.1194\/jlr.RA120000909_bib33","doi-asserted-by":"crossref","first-page":"a004788","DOI":"10.1101\/cshperspect.a004788","article-title":"Glycosphingolipid functions","volume":"3","author":"Lingwood","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1194\/jlr.RA120000909_bib34","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/42408","article-title":"Functional rafts in cell membranes","volume":"387","author":"Simons","year":"1997","journal-title":"Nature."},{"key":"10.1194\/jlr.RA120000909_bib35","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1083\/jcb.126.2.353","article-title":"Cysteine3 of Src family protein tyrosine kinase determines palmitoylation and localization in caveolae","volume":"126","author":"Shenoy-Scaria","year":"1994","journal-title":"J. Cell Biol."},{"key":"10.1194\/jlr.RA120000909_bib36","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.1074\/jbc.271.11.6518","article-title":"Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae","volume":"271","author":"Shaul","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.RA120000909_bib37","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10719-007-9084-6","article-title":"Involvement of very long fatty acid-containing lactosylceramide in lactosylceramide-mediated superoxide generation and migration in neutrophils","volume":"25","author":"Iwabuchi","year":"2008","journal-title":"Glycoconj. J."},{"key":"10.1194\/jlr.RA120000909_bib38","doi-asserted-by":"crossref","first-page":"20960","DOI":"10.1074\/jbc.M702436200","article-title":"Caveolin-associated accumulation of globotriaosylceramide in the vascular endothelium of alpha-galactosidase A null mice","volume":"282","author":"Shu","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.RA120000909_bib39","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/14084","article-title":"Cholesterol modulates membrane traffic along the endocytic pathway in sphingolipid-storage diseases","volume":"1","author":"Puri","year":"1999","journal-title":"Nat. Cell Biol."},{"key":"10.1194\/jlr.RA120000909_bib40","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1086\/507705","article-title":"Fabry disease in mice protects against lethal disease caused by Shiga toxin-expressing enterohemorrhagic Escherichia coli","volume":"194","author":"Cilmi","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1194\/jlr.RA120000909_bib41","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/hmg\/ddx032","article-title":"Tetrahydrobiopterin deficiency in the pathogenesis of Fabry disease","volume":"26","author":"Shen","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1194\/jlr.RA120000909_bib42","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1681\/ASN.2008111190","article-title":"Decreased nitric oxide bioavailability in a mouse model of Fabry disease","volume":"20","author":"Shu","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1194\/jlr.RA120000909_bib43","doi-asserted-by":"crossref","first-page":"G140","DOI":"10.1152\/ajpgi.00185.2013","article-title":"Endothelial nitric oxide synthase uncoupling and microvascular dysfunction in the mesentery of mice deficient in alpha-galactosidase A","volume":"306","author":"Kang","year":"2014","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1194\/jlr.RA120000909_bib44","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pharmthera.2009.01.003","article-title":"Fabry disease","volume":"122","author":"Schiffmann","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1194\/jlr.RA120000909_bib45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1471-2377-11-61","article-title":"Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel","volume":"11","author":"Burlina","year":"2011","journal-title":"BMC Neurol."},{"key":"10.1194\/jlr.RA120000909_bib46","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.1072-06.2006","article-title":"Intense isolectin-B4 binding in rat dorsal root ganglion neurons distinguishes C-fiber nociceptors with broad action potentials and high Nav1.9 expression","volume":"26","author":"Fang","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1194\/jlr.RA120000909_bib47","doi-asserted-by":"crossref","first-page":"e99171","DOI":"10.1172\/jci.insight.99171","article-title":"Neuropathic pain in a Fabry disease rat model","volume":"3","author":"Miller","year":"2018","journal-title":"JCI Insight."},{"key":"10.1194\/jlr.RA120000909_bib48","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1212\/WNL.0000000000004396","article-title":"Human dorsal root ganglion in vivo morphometry and perfusion in Fabry painful neuropathy","volume":"89","author":"Godel","year":"2017","journal-title":"Neurology."},{"key":"10.1194\/jlr.RA120000909_bib49","doi-asserted-by":"crossref","first-page":"e47988","DOI":"10.1371\/journal.pone.0047988","article-title":"TRPA1 is functionally expressed primarily by IB4-binding, non-peptidergic mouse and rat sensory neurons","volume":"7","author":"Barabas","year":"2012","journal-title":"PLoS One."},{"key":"10.1194\/jlr.RA120000909_bib50","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00441-014-1922-9","article-title":"Depletion of globosides and isoglobosides fully reverts the morphologic phenotype of Fabry disease","volume":"358","author":"Porubsky","year":"2014","journal-title":"Cell Tissue Res."},{"key":"10.1194\/jlr.RA120000909_bib51","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1460-9568.2008.06308.x","article-title":"GDNF hyperalgesia is mediated by PLCgamma, MAPK\/ERK, PI3K, CDK5 and Src family kinase signaling and dependent on the IB4-binding protein versican","volume":"28","author":"Bogen","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1194\/jlr.RA120000909_bib52","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/cne.20355","article-title":"Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders","volume":"480","author":"McGlynn","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1194\/jlr.RA120000909_bib53","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1007\/s11064-012-0761-x","article-title":"Abnormal gangliosides are localized in lipid rafts in Sanfilippo (MPS3a) mouse brain","volume":"37","author":"Dawson","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1194\/jlr.RA120000909_bib54","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1096\/fj.02-0149fje","article-title":"Phosphatidylcholine synthesis is elevated in neuronal models of Gaucher disease due to direct activation of CTP:phosphocholine cytidylyltransferase by glucosylceramide","volume":"16","author":"Bodennec","year":"2002","journal-title":"FASEB J."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520437290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520437290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.RA120000909","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T00:05:29Z","timestamp":1637453129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520437290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0022227520437290"],"URL":"https:\/\/doi.org\/10.1194\/jlr.ra120000909","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]}}}